Conference
412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors
Authors
Chu QS; Kim SW; Ellis PM; Mileshkin L; de Boer RH; Park JS; Pellas T; Huang F; Finckenstein FG; Dhar A
Volume
8
Publisher
Elsevier
Publication Date
November 1, 2010
DOI
10.1016/s1359-6349(10)72119-4
Conference proceedings
European Journal of Cancer Supplements
Issue
7
ISSN
1359-6349